Clinical Trial Update: Sequential Angiogenic Blockade for the Treatment of Recurrent Mullerian Malignancies [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating sequential angiogenic blockade for recurrent Mullerian malignancies, completed with results posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fallopian Tube Cancer
• Ovarian Cancer
• Peritoneal Cancer

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Ovarian Cancer, Peritoneal Cancer | Phase 2 | Status: COMPLETED | Results posted: 2016-05-17